TOP STORIES FROM SNM
SNM meeting opens with call for effectiveness researchSALT LAKE CITY - Appropriate comparative effectiveness research must be developed and utilized to justify the efficacy of nuclear medicine in guiding patient treatment and in the development of new technologies and pharmaceuticals, according to keynote speaker Larry Kessler, ScD.
SNM: 1 year later, Mo-99 shortage 'a lot worse'
SALT LAKE CITY - The worldwide molybdenum-99 (Mo-99) shortage is no closer to a solution than it was a year ago; in fact, it's "a lot worse" than in June 2009, when attention about the crisis peaked at SNM's annual meeting in Toronto.
Radiation dose must be reduced for molecular breast imaging
SALT LAKE CITY - Although molecular breast imaging techniques have the potential to carve out a role in screening, dose must be lowered to achieve a comparable benefit-to-risk ratio to mammography, according to a study presented Monday at the SNM annual meeting.
MORE NEWS FROM SNM
SPECT/CT helps guide management of diabetic foot infectionNovel agents and new tools chart molecular imaging's future
PET/CT may improve therapy for congestive heart failure patients
Image Gently expands dose awareness to nuclear medicine
SNM convenes annual meeting as challenges persist
GE touts PET agent study at SNM
Cell>Point touts SPECT agent results at SNM
Bioscan launches new products at SNM
GE debuts cyclotron, workstation at SNM
Hopkins group presents on SPECT/MRI unit
Lantheus touts results for PET agent at SNM
Sofie inks preclinical R&D deal with OsiriX
Cardinal debuts data tools at SNM
Lantheus reports F-18 cardiac PET findings
Philips rolls out nuclear medicine upgrades
Siemens unveils SNM molecular additions
Mirada debuts Caseaccess software
Philips begins selling PET/CT unit in U.S.
Lantheus touts SNM papers
Medrad, Pinestar team up
